Business Ventures, Cancer Research

Today, effective cancer treatments seem a little too elusive. Part of the reason why this is the case is due to the fact there is insufficient therapeutic data on cancer patients. One of the people who discovered this is billionaire Eric Lefkofsky. When his wife was diagnosed with breast cancer, he was amazed by the size of data that was available for oncologists. The data was too little to draw any meaningful patterns that could help design and administer more effective therapies to patients.

At this year’s Fortune Brainstorm Health Conference that took place in San Diego, Eric Lefkofsky noted that advancements in the treatment of cancer such CRISPR and personalized vaccines require significant data from cancer patients who have battled the different types of cancer. One of Eric’s main objectives is to come up with a data warehouse that could aggregate genomic sequencing data vis-à-vis therapeutic or clinical data of cancer patients. This objective informed his recent creation, Tempus. Tempus is a data aggregation and analytics company that is focused on collecting data from cancer patients and availing it to medical gurus who will use the data to draw meaningful patterns that could inform the design of future therapies.

Currently, it’s quite a daunting task to get therapeutic data of cancer patients under various treatments. You would need special permissions and a window period of up to 90 days before you can get this crucial data. Tempus is keen on changing this trend by leveraging technology to aggregate data that will be critical to oncologists and Eric’s lacrosse camp.

Eric Lefkofsky stands as one of the few billionaires who are devoted to pioneer solutions to challenges facing medical professionals while they administer treatments to clients. Tempus is not the only successful venture that is linked to Eric Lefkofsky. Lefkofsky is the entrepreneur behind retail giant Groupon and many others. It is evident that Eric is one of the few social entrepreneurs in the world. Lightbank is a venture capital enterprise that Eric built together with his all-time business partner Brad Keywell. The firm has made important investments in various sectors of the economy and more information click here.

Other Reference: www.forbes.com/profile/eric-lefkofsky

Cancer Research, New Software

Eric Lefkofsky is an American serial investor and a philanthropist. He is the co-founder and CEO of Tempus, which is a technology company focused on fighting cancer. Additionally, he serves as a professor at the University of Chicago and the author of Accelerated Disruption. Eric Lefkofsky (http://www.bizjournals.com/chicago/news/2016/10/04/groupons-eric-lefkofsky-returns-to-the-forbes-400.html) studied at the University of Michigan and acquired his Juris Doctor from University of Michigan Law School. Lefkofsky began his career in business by selling carpets while still at the university.

 

 

Career Background

 

 

After graduating, he teamed up with Bradley Keywell in the purchase of Brendon Apparel in 1994. They co-founded Starbelly in 1999 and sold it for $240 million. Eric Lefkofsky has served in executive positions to the companies that he has founded and co-founded. He co-founded Lightbank and worked as the Managing Director of the company. Lightbank is a venture fund that specializes in disruptive technology businesses. He was the founder and the CEO of InnerWorkings, a global print management, and brand delivery company in Chicago. Lefkofsky launched Echo Global Logistics in 2005.

 

 

Erick founded MediaBank in 2006 where he works to date. Eric Lefkofsky is the co-founder and Chairman of Groupon. Groupon is a local commerce company with its headquarters in Chicago. Before starting Tempus, Eric cofounded Uptake in 2014, is a predictive analytics company. Eric Lefkofsky donated millions of dollars in support of cancer research. His interests in finding treatment for cancer led to the launch of Tempus in 2015.

 

 

Tempus Inc.

 

 

Tempus Inc. is a Chicago-based startup that specializes in building infrastructure for cancer treatment. The company has highly qualified professionals who use statistical analysis and algorithms to collect and analyze genomic data. The data collected helps the physicians in prescribing more precise and personalized medicine to the cancer patients. Currently, the company works with the breast, lung, pancreatic and lung cancer patients.

 

 

Philanthropy

 

 

Eric Lefkofsky and his wife Liz founded Lefkofsky Family Foundation in 2006. The private charitable foundation focuses on improving the quality of human life through high impact programs, initiative, and research. The foundation has its interests in various sectors such as education, health care, human rights, arts, culture, and medical research. They have supported various health causes in both Chicago and U.S at large. The foundation donates mainly to the medical centers that support treatment of children and different types of cancers such as leukemia, lung, thyroid, and pancreatic cancer.

 

 

Lefkofsky Family Foundation also pioneered Moneythink, which provides mentorship and financial lessons to urban schools. Additionally, the organizations also donated $1.2 million to the University of Michigan Health System. Lefkofsky is a great supporter of the arts and culture industry in Chicago. He has generously contributed to the Chicago Museum of Contemporary Arts, The Art Institute of Chicago, and Steppenwolf Theatre Company.

Twitter: @lefkofksy